Invoke Bio
Invoke Bio designs personalised neoantigen vaccines in whatever form suits the patient, peptide, DNA or mRNA, using a prediction engine it says picks tumour targets with three times the accuracy of industry baselines.
Overview
Invoke Bio's immunogenicity prediction engine identifies tumour neoantigens for personalised vaccines and is modality-agnostic, supporting peptide, DNA and mRNA formats. Future of Cancer Care Today lists it as patient-orderable.
Similar pages
not linked directly; found by shared links- InstitutionHouston Methodist Center for RNA Therapeutics
Shares Personalised neoantigen (mRNA) vaccines and the tag fcct-directory.
- CompanyJaime Leandro Foundation
Shares Personalised neoantigen (mRNA) vaccines and the tag fcct-directory.
- CompanyUbiVac
Shares Personalised neoantigen (mRNA) vaccines and the tag fcct-directory.
- InstitutionCeCurio (MVZ Tübingen oncology)
Shares Personalised neoantigen (mRNA) vaccines and the tag fcct-directory.
- CompanyCeGaT
Shares Personalised neoantigen (mRNA) vaccines and the tag fcct-directory.